非男性因素不孕患者行卵胞浆内单精子注射与体外受精授精联合胚胎植入前非整倍体遗传学检测的结局比较:基于美国辅助生殖技术协会临床结局报告系统数据的分析
该回顾性队列研究基于美国辅助生殖技术协会数据库,纳入30,446个非男性因素行胚胎植入前非整倍体遗传学检测的周期,其中体外受精授精4,867个、卵胞浆内单精子注射授精25,579个。经排除标准及混杂因素校正后,两组可移植胚胎比例分别为41.6%与42.5%,活产率分别为50.1%与50.8%,均无显著差异。
要点
- 非男性因素行胚胎植入前非整倍体遗传学检测的周期中,体外受精与卵胞浆内单精子注射授精的可移植胚胎比例无显著差异。
- 两种授精方式的活产率无显著差异。
- 研究基于美国辅助生殖技术协会数据库的回顾性队列数据。
核心结论
- 在非男性因素行胚胎植入前非整倍体遗传学检测的周期中,体外受精授精与卵胞浆内单精子注射授精的可移植胚胎比例和活产率均无显著差异。
研究设计与样本
- 回顾性队列研究,基于美国辅助生殖技术协会数据库,纳入30,446个非男性因素行胚胎植入前非整倍体遗传学检测的周期,其中体外受精授精4,867个、卵胞浆内单精子注射授精25,579个。
主要发现
- 经排除标准及必要混杂因素校正后,可移植胚胎比例在体外受精组为41.6%(40.6%,42.6%),在卵胞浆内单精子注射组为42.5%(42.0%,42.9%),两组无显著差异。
- 活产率在体外受精组为50.1%(37.8%,62.4%),在卵胞浆内单精子注射组为50.8%(38.5%,62.9%),两组无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether insemination via intracytoplasmic sperm injection (ICSI) provides any benefit over in vitro fertilization (IVF) insemination for nonmale factor infertility with respect to preimplantation genetic testing (PGT) results and pregnancy outcome. DESIGN: Retrospective cohort study of the Society for Assisted Reproductive Technology database. SETTINGS: US-based fertility clinics reporting to the Society for Assisted Reprodcutive Technology. PATIENTS: Patients undergoing IVF or ICSI inseminations in nonmale factor PGT for aneuploidy cycles. INTERVENTION: In vitro fertilization vs. ICSI inseminations. MAIN OUTCOME MEASURES: Primary outcomes were the percentage of embryos suitable for transfer and live birth rates (LBRs). Secondary outcomes included subgroup analysis for embryos suitable for transfer on cycles from patients ≥35-year-old vs. <35-year-old, ≤6 oocytes retrieved vs. >6 oocytes retrieved, and unexplained infertility. Additionally, gestational age at delivery and birth weight between IVF and ICSI inseminations were evaluated. RESULTS: A total of 30,446 nonmale factor PGT diagnoses for aneuploidy cycles were evaluated, of which 4,867 were IVF inseminations and 25,579 were ICSI inseminations. Following exclusion criteria and adjustment for any necessary confounding variables, no significant differences existed in embryos suitable for transfer between IVF and ICSI treatment cycles, 41.6% (40.6%, 42.6%) vs. 42.5% (42.0%, 42.9%), respectively, or in LBRs, 50.1% (37.8, 62.4%) vs. 50.8% (38.5%, 62.9%), respectively. CONCLUSION: There were no significant differences in the rates of embryos suitable for transfer and LBRs between IVF and ICSI inseminations in nonmale factor cycles undergoing PGT for aneuploidy.
引用
- Tozour JN, Arnott A, Akerman M, et al. Comparison of outcomes between intracytoplasmic sperm injection and in vitro fertilization inseminations with preimplantation genetic testing for aneuploidy, analysis of Society for Assisted Reproductive Technology Clinic Outcome Reporting System data. Fertil Steril. 2024. PMID: 38185201. doi:10.1016/j.fertnstert.2023.12.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。